Loading clinical trials...
Loading clinical trials...
Randomised Study of First TIME Immunotolerance Induction in Patients With Severe Type A Haemophilia With Inhibitor at High Risk of Failure: Comparison of Induction of Immune Tolerance With FVIII Concentrates With or Without Von Willebrand Factor Acronym: RES.I.S.T.- Naive
Conditions
Interventions
FVIII Concentrates
FVIII/VWF concentrates
Start Date
September 25, 2009
Primary Completion Date
June 25, 2020
Completion Date
June 25, 2020
Last Updated
December 17, 2020
NCT05935358
NCT06703606
NCT05981274
NCT06938542
NCT07446010
NCT06136507
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions